{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:30Z","timestamp":1707524370405},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.7759\/cureus.20101","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T12:23:44Z","timestamp":1638447824000},"source":"Crossref","is-referenced-by-count":0,"title":["Neutropenic Fever in a Patient With SARS-CoV-2-Induced Hemophagocytic Lymphohistiocytosis (HLH)"],"prefix":"10.7759","author":[{"given":"Elliot","family":"Runge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Stoffel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Rendo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bradley W","family":"Beeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2016.05.001","article-title":"Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review","volume":"30","author":"Hayden A","year":"2016","unstructured":"Hayden A, Park S, Giustini D, Lee AY, Chen LY. Hemophagocytic syndromes (HPSs) including hemophagocytic lymphohistiocytosis (HLH) in adults: a systematic scoping review. Blood Rev. 2016, 30:411-20. 10.1016\/j.blre.2016.05.001","journal-title":"Blood Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30826","article-title":"A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults","volume":"123","author":"Daver N","year":"2017","unstructured":"Daver N, McClain K, Allen CE, et al.. A consensus review on malignancy-associated hemophagocytic lymphohistiocytosis in adults. Cancer. 2017, 123:3229-40. 10.1002\/cncr.30826","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-31. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-77. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05569-4","article-title":"Haemophagocytic syndrome and COVID-19","volume":"40","author":"Retamozo S","year":"2021","unstructured":"Retamozo S, Brito-Zer\u00f3n P, Sis\u00f3-Almirall A, Flores-Ch\u00e1vez A, Soto-C\u00e1rdenas MJ, Ramos-Casals M. Haemophagocytic syndrome and COVID-19. Clin Rheumatol. 2021, 40:1233-44. 10.1007\/s10067-020-05569-4","journal-title":"Clin Rheumatol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01682-y","article-title":"Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?","volume":"18","author":"Opoka-Winiarska V","year":"2020","unstructured":"Opoka-Winiarska V, Grywalska E, Roli\u0144ski J. Could hemophagocytic lymphohistiocytosis be the core issue of severe COVID-19 cases?. BMC Med. 2020, 18:214. 10.1186\/s12916-020-01682-y","journal-title":"BMC Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.\u200bjcrc.2017.02.018","article-title":"Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children","volume":"39","author":"Han X-C","year":"2017","unstructured":"Han X-C, Ye Q, Zhang W-Y, Tang Y-M, Xu X-J, Zhang T. Cytokine profiles as novel diagnostic markers of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children. J Crit Care. 2017, 39:72-7. 10.1016\/j.\u200bjcrc.2017.02.018","journal-title":"J Crit Care"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqaa124","article-title":"SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis","volume":"8","author":"Prilutskiy A","year":"2020","unstructured":"Prilutskiy A, Kritselis M, Shevtsov A, et al.. SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis. Am J Clin Pathol. 2020, 8:466-74. 10.1093\/ajcp\/aqaa124","journal-title":"Am J Clin Pathol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2015.1.177","article-title":"Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis","volume":"2015","author":"Allen CE","year":"2015","unstructured":"Allen CE, McClain KL. Pathophysiology and epidemiology of hemophagocytic lymphohistiocytosis. Hematol Am Soc Hematol Educ Program. 2015, 2015:177-82. 10.1182\/asheducation-2015.1.177","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2324709620950107","article-title":"Epstein-BarrvVirus versus novel coronavirus-induced hemophagocytic lymphohistocytosis: the uncharted waters","volume":"8","author":"Amir R","year":"2020","unstructured":"Amir R, Kichloo A, Singh J, et al.. Epstein-BarrvVirus versus novel coronavirus-induced hemophagocytic lymphohistocytosis: the uncharted waters. J Investig Med High Impact Case Rep. 2020, 8:2324709620950107. 10.1177\/2324709620950107","journal-title":"J Investig Med High Impact Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh RA","year":"2010","unstructured":"Marsh RA, Vaughn G, Kim MO, et al.. Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation. Blood. 2010, 116:5824-31. 10.1182\/blood-2010-04-282392","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-020-02503-9","article-title":"Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report","volume":"14","author":"Tholin B","year":"2020","unstructured":"Tholin B, Hauge MT, Aukrust P, Fehrle L, Tvedt TH. Hemophagocytic lymphohistiocytosis in a patient with COVID-19 treated with tocilizumab: a case report. J Med Case Rep. 2020, 14:187. 10.1186\/s13256-020-02503-9","journal-title":"J Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105954","article-title":"Cytokine release syndrome in severe COVID- 19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality","volume":"55","author":"Zhang C","year":"2020","unstructured":"Zhang C, Wu Z, Li JW, Zhao H, Wang GQ. Cytokine release syndrome in severe COVID- 19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020, 55:105954. 10.1016\/j.ijantimicag.2020.105954","journal-title":"Int J Antimicrob Agents"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00211","article-title":"NLRP3 inflammasome-a key player in antiviral responses","volume":"18","author":"Zhao C","year":"2020","unstructured":"Zhao C, Zhao W. NLRP3 inflammasome-a key player in antiviral responses. Front Immunol. 2020, 18:211. 10.3389\/fimmu.2020.00211","journal-title":"Front Immunol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15232","article-title":"A tale of two antibodies: obinutuzumab versus rituximab","volume":"182","author":"Freeman CL","year":"2018","unstructured":"Freeman CL, Sehn LH. A tale of two antibodies: obinutuzumab versus rituximab. Br J Haematol. 2018, 182:29-45. 10.1111\/bjh.15232","journal-title":"Br J Haematol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-788349","article-title":"Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study","volume":"21","author":"Bergsten E","year":"2017","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, et al.. Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 2017, 21:2728-38. 10.1182\/blood-2017-06-788349","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15988","article-title":"Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis","volume":"186","author":"Song Y","year":"2019","unstructured":"Song Y, Wang Y, Wang Z. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Br J Haematol. 2019, 186:717-23. 10.1111\/bjh.15988","journal-title":"Br J Haematol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/64729-neutropenic-fever-in-a-patient-with-sars-cov-2-induced-hemophagocytic-lymphohistiocytosis-hlh","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:31:42Z","timestamp":1707507102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/64729-neutropenic-fever-in-a-patient-with-sars-cov-2-induced-hemophagocytic-lymphohistiocytosis-hlh"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,2]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.20101","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,2]]}}}